Risk factors related to mortality in patients with septicemia causing by Aeromonas hydrophila
Main Article Content
Abstract
This cross-sectional, descriptive study was conducted to evaluate the outcome and explore the risk factors related to mortality of A. hydrophila septicemia in patients treated at the National Hospital of Tropical Diseases from 2018 to 2024. Of 37 patients included in the study, 3 patients had septic shock, mainly appearing within 5 days after the onset. 26 patients (70.3%) recovered but 11 patients (29.7%) passed on, of which 6 patients passed within the first 3 days of hospitalization. After 3 days of treatment, the median procalcitonin (PCT) level and SOFA score was lower than the first day of hospitalization. After 7 days of treatment, the level of CRP, procalcitonin, bilirubin, creatinine, AST, ALT, and SOFA scores decreased significantly compared to the day of admission. Multivariate logistic regression analysis showed that septic shock was an independent factor associated with mortality. In conclusion, septicemia caused by A. hydrophila is a severe disease with high rates of shock and mortality. Septic shock often appears within the first 5 days after the onset and is an independent factor related to mortality.
Article Details
Keywords
Septicemia, A. hydrophila, risk factor, mortality
References
2. Janda JM, Abbott SL. The genus Aeromonas: taxonomy, pathogenicity, and infection. Clinical microbiology reviews. Jan 2010;23(1):35-73. doi:10.1128/ cmr.00039-09
3. Mukherjee S, Das S, Mukherjee S, et al. Arterial Blood Gas as a Prognostic Indicator in Patients with Sepsis. Indian journal of medical microbiology.2020;38(3):457-460. doi:https://doi.org/10.4103/ijmm.IJMM_19_478
4. Ko WC, Chuang YC. Aeromonas bacteremia: review of 59 episodes. Clinical infectious diseases: an official publication of the Infectious Diseases Society of America. May 1995;20(5):1298-304. doi:10.1093/clinids/20.5.1298
5. Veeren G, Haripriya Reddy C, Nandini S, et al. Infections caused by Aeromonas species in hospitalized patients: A case series. Indian journal of medical microbiology. Apr-Jun 2022;40(2):306-308. doi:10.1016/j.ijmmb.2022.01.006
6. Tsai YH, Shen SH, Yang TY, et al. Monomicrobial Necrotizing Fasciitis Caused by Aeromonas hydrophila and Klebsiella pneumoniae. Medical principles and practice : international journal of the Kuwait University, Health Science Centre. 2015;24(5):416-23. doi:10.1159/000431094
7. Wu CJ, Lee HC, Chang TT, et al. Aeromonas spontaneous bacterial peritonitis: a highly fatal infectious disease in patients with advanced liver cirrhosis. Journal of the Formosan Medical Association. Apr 2009;108(4):293-300. doi:10.1016/s0929-6646(09)60069-3
8. Chan FK, Ching JY, Ling TK, et al. Aeromonas infection in acute suppurative cholangitis: review of 30 cases. The Journal of infection. Jan 2000;40(1):69-73. doi:10.1053/jinf.1999.0594
9. Bùi Thị Thúy. Đặc điểm lâm sàng, cận lâm sàng bệnh nhân nhiễm khuẩn huyết do Aeromonas hydrophila điều trị tại Bệnh viện Bệnh Nhiệt đới Trung ương. Luận văn thạc sĩ. Trường Đại học Y Hà Nội; 2016.
10. Dumančić J, Čupić M, Potočnjak I, et al. The effectiveness of synthetic glucocorticoids on the disease course, treatment, and outcome of severe sepsis and septic shock. J Endocrine oncology metabolism. 2016;2(1):72-81.
11. Hochedez P, Hope-Rapp E, Olive C, et al. Bacteremia caused by Aeromonas species [corrected] complex in the Caribbean Islands of Martinique and Guadeloupe. The American journal of tropical medicine and hygiene. Nov 2010;83(5):1123-7. doi:10.4269/ajtmh.2010.10-0063
12. Chuang HC, Ho YH, Lay CJ, et al. Different clinical characteristics among Aeromonas hydrophila, Aeromonas veronii biovar sobria and Aeromonas caviae monomicrobial bacteremia. Journal of Korean medical science. Nov 2011;26(11):1415-20. doi:10.3346/jkms.2011.26.11.1415
13. Choi JP, Lee SO, Kwon HH, et al. Clinical significance of spontaneous Aeromonas bacterial peritonitis in cirrhotic patients: a matched case-control study. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. Jul 1 2008;47(1):66-72. doi:10.1086/588665
14. Liu D, Su L, Han G, et al. Prognostic Value of Procalcitonin in Adult Patients with Sepsis: A Systematic Review and Meta-Analysis. PloS one. 2015;10(6):e0129450. doi:10.1371/journal.pone.0129450
15. Lim H-K, Bair MJ, Lee C-M, et al. Aeromonas Hydrophila Infection: 6-Year Experience and. J Taiwan Emerg Med. 2010;20:42.
16. Rhee JY, Jung DS, Peck KR. Clinical and Therapeutic Implications of Aeromonas Bacteremia: 14 Years Nation-Wide Experiences in Korea. Infection & chemotherapy. Dec 2016;48(4):274-284. doi:10.3947/ic.2016.48.4.274
17. Nguyễn Tất Dũng, Trần Đức Huy, Hoàng Trọng Hanh, và cs. Giá trị tiên lượng của khí máu động mạch ở bệnh nhân nhiễm khuẩn nặng và sốc nhiễm khuẩn. Tạp chí Y học lâm sàng Bệnh viện Trung ương Huế. 2023;(87); doi: 10.38103/jcmhch.87.10